PAXERAPACS— 510(k) K132586

Substantially Equivalent

Paxeramed

FDA 510(k) clearance K132586 for PAXERAPACS, Substantially Equivalent on 2013-10-31. Applicant: Paxeramed.

Clearance details

Applicant: Paxeramed
Product code: Code LLZ
Advisory panel: Radiology
Date received: 2013-08-16
Decision date: 2013-10-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Aubrey, TX, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.